Miscellaneous
We are back! The first episode of Season 2 of the Personalized Medicine Podcast is out! In this episode, our host Oleksandr Yagensky sat down with Dr. Oliver Rinner, co-founder, and CEO of Biognosys, a proteomics technology company. We discussed the growing role of proteomics in healthcare, its impact on biomarker discovery, and the development of new therapeutics. Together with Oliver, we talk about: ◦ Startup story of Biognosys ◦ Transitioning from academia to entrepreneurship ◦ Impact of proteomics on pharma industry ◦ Role of proteomics in biomarker discovery ◦ Differences between targeted and discovery mass spectrometry ◦ Role of AI and ML in the analysis of OMICs data ◦ How can proteomics take up a mainstream role in clinical diagnostics? ◦ The outlook on the personalized medicine of the futureGet in touch with Oliver: ◦ Twitter: @oliverrinner, @biognosys ◦ Linkedin: https://www.linkedin.com/in/orinner/ ◦ Web: https://biognosys.com/Make sure to download the full show notes with our guest's bio, links to their most notable work, and our recommendations for further reads on the topic of the episode at pmedcast.com